GlassScriptPhysician profile
Kevin A Mansmann
NPI 1114923752
$6,276.93
in general payments reported to CMS, 2019-2025
20 companies · $30.03 in 2025
The $30.03 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $81.68 · 2021: $96.17 · 2023: $5,728 · 2024: $129 · 2025: $30.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,450 · Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,450.20 |
| Food and Beverage | $437.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $5,450.20 | 2023 | |
| Depuy Synthes Sales INC. | $161.31 | 2019-2024 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $126.81 | 2019-2020 | |
| Stryker Corporation | $64.54 | 2023 | Gamma, Omega, Alphavent |
| Abbott Laboratories | $59.77 | 2024-2025 | Octrode |
| Sanofi-Aventis U.S. LLC | $55.95 | 2019-2023 | |
| Ibsa Pharma INC. | $48.35 | 2023-2024 | Tirosint, Tirosint, Licart |
| Heraeus Medical, LLC. | $48.12 | 2023-2024 | Palacos |
| Zimmer Biomet Holdings, INC. | $43.86 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $42.29 | 2023 | Seglentis |
| Alexion Pharmaceuticals, INC. | $22.84 | 2023 | Strensiq |
| Fidia Pharma USA INC. | $22.05 | 2020 | |
| Ferring Pharmaceuticals INC. | $21.01 | 2023 | Euflexxa |
| Averitas Pharma INC. | $20.66 | 2023 | Qutenza |
| Ermi LLC | $20.54 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $20.45 | 2019 | |
| Trevena, INC. | $18.88 | 2021 | |
| Djo, LLC | $11.17 | 2019 | |
| Globus Medical, INC. | $10.12 | 2020 | |
| Orthofix Medical, INC. | $8.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mansmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.